Eli Lilly to sell low blood sugar drug to Amphastar

Amphastar Pharmaceuticals

24/04/2023 11:53

April 24 (Reuters) - Eli Lilly and Co  LLY.N  will sell
its low blood sugar drug Baqsimi to Amphastar Pharmaceuticals
 AMPH.O  for over $500 million in cash, the two companies said
on Monday.
    Amphastar will pay $500 million at closing and another $125
million in cash after one year under the deal.

 (Reporting by Leroy Leo in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))